[{"Assets_0_Q2_USD":"1276100000.0","CIK":"899923","CommonStockSharesConverted_0_Q2_shares":"68100000.0","CommonStockSharesOutstanding_0_Q2_shares":"68100000.0","Country":"United States","EarningsPerShareBasic_1_Q2_USD":"0.09","EarningsPerShareBasic_2_Q2_USD":"0.07","EarningsPerShareDiluted_1_Q2_USD":"0.09","EarningsPerShareDiluted_2_Q2_USD":"0.07","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","Market Cap":"1850258412.0","NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":"28500000.0","NetIncomeLossConverted_1_Q2_USD":"5900000.0","NetIncomeLossConverted_2_Q2_USD":"4700000.0","OfficialName":"Myriad Genetics Inc. Common Stock","RevenuesConverted_1_Q2_USD":"196500000.0","RevenuesConverted_2_Q2_USD":"373900000.0","SP500":null,"Sector":"Health Care","StockholdersEquityConverted_0_Q2_USD":"732700000.0","StockholdersEquity_0_Q2_USD":"732900000.0","Ticker":"MYGN","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":"68300000.0","WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":"68900000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":"68200000.0","WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":"68500000.0","filed":"20170208","footnote":null,"form":"10-Q","fp":"Q2","fy":"2017.0","name":"MYRIAD GENETICS INC","period":"20161231","qtrs":"0","uom":"USD"}]